Zia Ullah
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Zia Ullah has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
- Zain Ul Abedeen
Department of medicine, Saidu Medical College, Swat, Pakistan
11 shared publications - Abad Ur Rehman
Department of Medicine Spinghar University (Kabul Campus) Kabul Afghanistan
5 shared publications - Ayesha Saleem
Saidu Medical College, Swat, Pakistan
3 shared publications Muhammad Zaib
Saidu Medical College, Swat, Pakistan
3 shared publications- Naeem Ullah
Department of Medicine Saidu Medical College Swat Pakistan
3 shared publications - Abdur Rehman
Department of medicine, Saidu Medical College, Swat, Pakistan
2 shared publications
Latest Publications
- Open Access
- 14 October 2026
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (11) , 7388-7398
Advances in the prevention and management of postoperative nausea and vomiting: a narrative review of pharmacological and integrative approaches
Postoperative nausea and vomiting (PONV) remain a major complication following surgery. Despite the availability of numerous therapies and international guidelines, it affects approximately 25–30% of patients, with rates reaching 80% among high-risk patients. There are currently no effective measures to completely eliminate the risk of PONV partly because of varying guidelines, the high cost of preventive approaches, and inconsistencies in their use across different clinical settings. Therefore, this narrative review aimed to synthesize the most up-to-date evidence on the prevention and management of PONV. A literature review was performed using MEDLINE and Google Scholar from January 2020 to July 2025 and included meta-analyses, RCTs, and systematic and narrative reviews published after the 2020 guidelines on the management of PONV. Current evidence supports an individualized and multimodal approach to the prevention of PONV, based on artificial intelligence (AI)-assisted risk stratification using the Apfel and Koivuranta scores. In addition, evidence from the literature includes several new pharmacological agents that can be used as adjuncts to established therapies. These include NK-1 antagonists, long-acting 5-HT3 antagonists, and repurposed medications such as midazolam, olanzapine, mirtazapine, and pyridoxine. Evidence regarding integrative approaches, including acustimulation, acupuncture, music, and gum therapy, is promising and appears to be cost-effective. Therefore, the use of individualized multimodal PONV management that combines pharmacological and non-pharmacological strategies will improve the overall prevention of PONV and patient satisfaction. There is a need for further studies of the relationship between pharmacogenomics, AI-assisted risk prediction, and the cost-effectiveness of PONV management in various health care settings.
- 14 October 2026
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (11) , 7388-7398
Open AccessAdvances in the prevention and management of postoperative nausea and vomiting: a narrative review of pharmacological and integrative approaches
Postoperative nausea and vomiting (PONV) remain a major complication following surgery. Despite the availability of numerous therapies and international guidelines, it affects approximately 25–30% of patients, with rates reaching 80% among high-risk patients. There are currently no effective measures to completely eliminate the risk of PONV partly because of varying guidelines, the high cost of preventive approaches, and inconsistencies in their use across different clinical settings. Therefore, this narrative review aimed to synthesize the most up-to-date evidence on the prevention and management of PONV. A literature review was performed using MEDLINE and Google Scholar from January 2020 to July 2025 and included meta-analyses, RCTs, and systematic and narrative reviews published after the 2020 guidelines on the management of PONV. Current evidence supports an individualized and multimodal approach to the prevention of PONV, based on artificial intelligence (AI)-assisted risk stratification using the Apfel and Koivuranta scores. In addition, evidence from the literature includes several new pharmacological agents that can be used as adjuncts to established therapies. These include NK-1 antagonists, long-acting 5-HT3 antagonists, and repurposed medications such as midazolam, olanzapine, mirtazapine, and pyridoxine. Evidence regarding integrative approaches, including acustimulation, acupuncture, music, and gum therapy, is promising and appears to be cost-effective. Therefore, the use of individualized multimodal PONV management that combines pharmacological and non-pharmacological strategies will improve the overall prevention of PONV and patient satisfaction. There is a need for further studies of the relationship between pharmacogenomics, AI-assisted risk prediction, and the cost-effectiveness of PONV management in various health care settings.
- Open Access
- 11 October 2026
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 25 (10) , e71227
OX40 – OX40L Structural Insights Applied to Rocatinlimab in Atopic Dermatitis With Alopecia Areata Overlap: Mechanistic Hypotheses and Hair Regrowth
- 11 October 2026
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 25 (10) , e71227
Open AccessOX40 – OX40L Structural Insights Applied to Rocatinlimab in Atopic Dermatitis With Alopecia Areata Overlap: Mechanistic Hypotheses and Hair Regrowth
- Open Access
- 22 September 2026
- Published by Springer Nature in Egyptian Journal of Neurosurgery
- Vol. 41 (1) , 163
Transcranial magnetic stimulation in autism spectrum disorder: a narrative review of neurobiological mechanisms, clinical efficacy, and future directions
Background: Autism Spectrum Disorder (ASD) is a complicated neuropsychological disorder associated with social communicational problems, stereotypical interests, and behavior patterns. Though ASD has many causes, there are no treatment modalities today that have an overall impact on the condition itself, leaving room for improvement in existing approaches. Transcranial Magnetic Stimulation (TMS) is one of the innovative approaches to treat such disorders by means of a noninvasive method of neuron activation using a strong magnetic field. Body: The TMS could have an influence on the interconnection of the brain networks, synaptic plasticity, and the brain cortex excitability, which are associated with the alleviation of the symptoms of ASD. Although some randomized and open-label studies have reported improvement, the evidence is weakened by small samples, inconsistent protocols, and the large proportion of uncontrolled studies. This would mean that the process of selecting patients as well as administering TMS would need careful attention. There are no documented long-term impacts of TMS. For future studies, there should be incorporation of the principles from neuroimaging and electrophysiology. TMS is performed using different techniques depending on its objectives, which include single-pulse TMS that assesses brain topography; paired-pulse TMS in evaluating the inhibitory or facilitating nature of the brain cortex; repetitive TMS (rTMS). Conclusion: It can be concluded from all the information presented above that TMS might have immense potential as an add-on treatment for ASDs based on the data we have accumulated. However, more studies are needed to assess the efficacy of this treatment method in addressing ASDs.To summarize, TMS is a relatively novel neuromodulation therapy that can benefit individuals with ASDs based on the neurobiological aspects of their disorders.
- 22 September 2026
- Published by Springer Nature in Egyptian Journal of Neurosurgery
- Vol. 41 (1) , 163
Open AccessTranscranial magnetic stimulation in autism spectrum disorder: a narrative review of neurobiological mechanisms, clinical efficacy, and future directions
Background: Autism Spectrum Disorder (ASD) is a complicated neuropsychological disorder associated with social communicational problems, stereotypical interests, and behavior patterns. Though ASD has many causes, there are no treatment modalities today that have an overall impact on the condition itself, leaving room for improvement in existing approaches. Transcranial Magnetic Stimulation (TMS) is one of the innovative approaches to treat such disorders by means of a noninvasive method of neuron activation using a strong magnetic field. Body: The TMS could have an influence on the interconnection of the brain networks, synaptic plasticity, and the brain cortex excitability, which are associated with the alleviation of the symptoms of ASD. Although some randomized and open-label studies have reported improvement, the evidence is weakened by small samples, inconsistent protocols, and the large proportion of uncontrolled studies. This would mean that the process of selecting patients as well as administering TMS would need careful attention. There are no documented long-term impacts of TMS. For future studies, there should be incorporation of the principles from neuroimaging and electrophysiology. TMS is performed using different techniques depending on its objectives, which include single-pulse TMS that assesses brain topography; paired-pulse TMS in evaluating the inhibitory or facilitating nature of the brain cortex; repetitive TMS (rTMS). Conclusion: It can be concluded from all the information presented above that TMS might have immense potential as an add-on treatment for ASDs based on the data we have accumulated. However, more studies are needed to assess the efficacy of this treatment method in addressing ASDs.To summarize, TMS is a relatively novel neuromodulation therapy that can benefit individuals with ASDs based on the neurobiological aspects of their disorders.
- 8 September 2026
- Published by Springer Nature in World Journal of Urology
- Vol. 44 (1) , 648
Comments on “Broad Applicability Is Not Size Independence: Interpreting Aquablation Outcomes Across Prostate Volumes”
- 8 September 2026
- Published by Springer Nature in World Journal of Urology
- Vol. 44 (1) , 648
Comments on “Broad Applicability Is Not Size Independence: Interpreting Aquablation Outcomes Across Prostate Volumes”
- Open Access
- 7 August 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (32) , e50088
Mixed phenotype acute leukemia mimicking adult-onset Still’s disease in a pregnant female: A rare case report
Introduction: Mixed phenotype acute leukemia (MPAL) is an uncommon hematologic malignancy characterized by the coexistence of lymphoid and myeloid lineage markers. Although adult-onset Still’s disease (AOSD) is a diagnosis of exclusion, MPAL may rarely present with similar laboratory and clinical findings, resulting in delayed diagnosis and treatment. Case presentation: We report a case of a 36-year-old woman who presented at 20 weeks of gestation with inflammatory polyarthritis, hyperferritinemia, lymphadenopathy, thrombocytopenia, and leukocytosis. The patient fulfilled the Yamaguchi criteria for AOSD after exclusion of autoimmune and infectious conditions and was initially treated with hydroxychloroquine and corticosteroids. An inefficient response to treatment and persistent cytopenias led to reevaluation. A repeat peripheral smear revealed blast cells, and flow cytometry confirmed MPAL. Gestation-compatible chemotherapy protocols resulted in a favorable clinical and hematologic response, with no adverse maternal or fetal outcomes. Clinical discussion: The clinical overlap between the manifestations of AOSD and MPAL may occasionally result in misdiagnosis and delayed detection of an underlying malignancy. In patients presenting with presumed AOSD, careful exclusion of hematologic cancers is essential, particularly in the presence of atypical features such as persistent systemic inflammation, cytopenias, or poor therapeutic response. Conclusion: This case describes a rare association between the manifestations of AOSD and MPAL. In addition, it highlights the importance of recognizing warning signs that may indicate an underlying malignancy in patients presenting with AOSD-like symptoms.
- 7 August 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (32) , e50088
Open AccessMixed phenotype acute leukemia mimicking adult-onset Still’s disease in a pregnant female: A rare case report
Introduction: Mixed phenotype acute leukemia (MPAL) is an uncommon hematologic malignancy characterized by the coexistence of lymphoid and myeloid lineage markers. Although adult-onset Still’s disease (AOSD) is a diagnosis of exclusion, MPAL may rarely present with similar laboratory and clinical findings, resulting in delayed diagnosis and treatment. Case presentation: We report a case of a 36-year-old woman who presented at 20 weeks of gestation with inflammatory polyarthritis, hyperferritinemia, lymphadenopathy, thrombocytopenia, and leukocytosis. The patient fulfilled the Yamaguchi criteria for AOSD after exclusion of autoimmune and infectious conditions and was initially treated with hydroxychloroquine and corticosteroids. An inefficient response to treatment and persistent cytopenias led to reevaluation. A repeat peripheral smear revealed blast cells, and flow cytometry confirmed MPAL. Gestation-compatible chemotherapy protocols resulted in a favorable clinical and hematologic response, with no adverse maternal or fetal outcomes. Clinical discussion: The clinical overlap between the manifestations of AOSD and MPAL may occasionally result in misdiagnosis and delayed detection of an underlying malignancy. In patients presenting with presumed AOSD, careful exclusion of hematologic cancers is essential, particularly in the presence of atypical features such as persistent systemic inflammation, cytopenias, or poor therapeutic response. Conclusion: This case describes a rare association between the manifestations of AOSD and MPAL. In addition, it highlights the importance of recognizing warning signs that may indicate an underlying malignancy in patients presenting with AOSD-like symptoms.
- 30 July 2026
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 44 (9) , 1657-1658
Methodological and interpretive concerns regarding “Asymmetric U-shaped association between first trimester maternal free thyroxine levels and the risk of preeclampsia”
Was not provided for this article.
- 30 July 2026
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 44 (9) , 1657-1658
Methodological and interpretive concerns regarding “Asymmetric U-shaped association between first trimester maternal free thyroxine levels and the risk of preeclampsia”
Was not provided for this article.
- Open Access
- 18 June 2026
- Published by Wiley in Clinical Case Reports
- Vol. 14 (6) , e72981
Bilateral Brucellar Sacroiliitis Mimicking Tuberculous or Inflammatory Spondyloarthropathy: A Case Report
Brucellosis is a zoonotic infection, endemic in rural areas. It is caused by Brucella species, which are transmitted through the intake of unpasteurized dairy products and contact with infected animals. Sacroiliac joint involvement is common in brucellosis and typically presents as unilateral sacroiliitis. Contrarily, bilateral sacroiliitis is less typical and may mimic tuberculosis, pyogenic infection, or inflammatory spondyloarthropathy. We report a case of a 19‐year‐old man who presented with a one‐month history of bilateral buttock pain radiating to the legs and a 2‐week history of fever, chills, rigors, and febrile diaphoresis. He reported unpasteurized milk intake. Physical examination revealed bilateral sacroiliac joint tenderness, and Patrick's and Gaenslen's provocation tests elicited pain in both sacroiliac joints. Laboratory findings showed leukocytosis, elevated CRP, and ESR. Standard agglutination testing was positive for anti‐Brucella antibodies, and MRI confirmed bilateral sacroiliitis, along with erosive changes and marrow edema. A diagnosis of brucellosis complicated by bilateral sacroiliitis was proposed. The patient was started on doxycycline, co‐trimoxazole, and gentamicin. Gentamicin was used for 22 days, while doxycycline and co‐trimoxazole were continued for a total planned duration of 13 weeks. During follow‐up visits (day 15 and day 45), the patient demonstrated clinical improvement, evident by laboratory parameters, pain improvement, no fever, difficulty walking, and medication‐related adverse effects. This case emphasizes that clinicians in endemic areas must consider brucellosis as a differential diagnosis in patients with bilateral lower back or buttock pain. MRI findings and serology testing are useful in early recognition. While blood cultures, PCR, and biopsy are necessary for definitive diagnosis.
- 18 June 2026
- Published by Wiley in Clinical Case Reports
- Vol. 14 (6) , e72981
Open AccessBilateral Brucellar Sacroiliitis Mimicking Tuberculous or Inflammatory Spondyloarthropathy: A Case Report
Brucellosis is a zoonotic infection, endemic in rural areas. It is caused by Brucella species, which are transmitted through the intake of unpasteurized dairy products and contact with infected animals. Sacroiliac joint involvement is common in brucellosis and typically presents as unilateral sacroiliitis. Contrarily, bilateral sacroiliitis is less typical and may mimic tuberculosis, pyogenic infection, or inflammatory spondyloarthropathy. We report a case of a 19‐year‐old man who presented with a one‐month history of bilateral buttock pain radiating to the legs and a 2‐week history of fever, chills, rigors, and febrile diaphoresis. He reported unpasteurized milk intake. Physical examination revealed bilateral sacroiliac joint tenderness, and Patrick's and Gaenslen's provocation tests elicited pain in both sacroiliac joints. Laboratory findings showed leukocytosis, elevated CRP, and ESR. Standard agglutination testing was positive for anti‐Brucella antibodies, and MRI confirmed bilateral sacroiliitis, along with erosive changes and marrow edema. A diagnosis of brucellosis complicated by bilateral sacroiliitis was proposed. The patient was started on doxycycline, co‐trimoxazole, and gentamicin. Gentamicin was used for 22 days, while doxycycline and co‐trimoxazole were continued for a total planned duration of 13 weeks. During follow‐up visits (day 15 and day 45), the patient demonstrated clinical improvement, evident by laboratory parameters, pain improvement, no fever, difficulty walking, and medication‐related adverse effects. This case emphasizes that clinicians in endemic areas must consider brucellosis as a differential diagnosis in patients with bilateral lower back or buttock pain. MRI findings and serology testing are useful in early recognition. While blood cultures, PCR, and biopsy are necessary for definitive diagnosis.